OrthoXel receives FDA 510(k) clearance of hip fracture nail
Key takeaways:
- OrthoXel received FDA 510(k) clearance of the Vertex hip fracture nail.
- The nail is indicated for use in hip fracture fixation procedures for various fracture types and patient anatomies.
OrthoXel announced FDA 510(k) clearance of the Vertex hip fracture nail. The Vertex hip fracture nail is indicated for use in fixation procedures for various fracture types and patient anatomies, according to a press release.
“With the exciting news of Vertex’s FDA 510(k) clearance, I eagerly anticipate this innovative nail providing benefit to my patients and those of other fracture surgeons,” Douglas R. Dirschl, MD, professor and chair of orthopedic Surgery at Baylor College of Medicine, said in the release.
Dirschl was involved in the product development process, according to the release.
“The Vertex’s design offers enhanced stability as well as the flexibility to tailor treatment to individual patient and fracture needs. Like with their Apex nail, the OrthoXel team has once again demonstrated excellence and innovation in product design,” Dirschl said.
Read more about